放射治疗在晚期食管鳞癌的地位及研究进展  

Advances and the status of radiotherapy in advanced esophageal cancer

作　　者：陈明月 颉微 周志国[3] 王军[3] 白文文[3] 甄婵军[3] 张萍[3] Chen Mingyue;Jie Wei;Zhou Zhiguo;Wang Jun;Bai Wenwen;Zhen Chanjun;Zhang Ping(Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Hebei Cancer Hospital,Chinese Academy of Medical Sciences,Langfang 065001,China;Department of Radiation Oncology,Baoji Central Hospital,Baoji 721008,China;Department of Radiation Oncology,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050000,China)

机构地区：[1]国家癌症中心/国家肿瘤临床医学研究中心/河北中国医学科学院肿瘤医院放疗科,廊坊065001 [2]宝鸡市中心医院放疗科,宝鸡721008 [3]河北医科大学第四医院放疗科,石家庄050000

出　　处：《中华放射肿瘤学杂志》2023年第6期562-566,共5页Chinese Journal of Radiation Oncology

摘　　要：放疗在晚期食管癌治疗中具有重要地位。在有效的全身治疗的前提下,筛选出可能从局部放射治疗中获益的患者进行治疗,可以有效缓解患者的症状及改善生活质量,并有望延长患者的生存时间。而且免疫治疗在晚期食管癌中的作用越来越显著,放疗与免疫治疗联合治疗的疗效令人期待。Radiotherapy plays an important role in the treatment of advanced esophageal cancer.Under the premise of effective systemic treatment,selecting patients who may benefit from local radiotherapy can effectively relieve symptoms and improve quality of life,and it is expected to prolong the survival time of patients.Moreover,immunotherapy plays an increasingly significant role in advanced esophageal cancer,and the efficacy of radiotherapy combined with immunotherapy is promising.

关 键 词：食管肿瘤 晚期 放射疗法 免疫疗法 联合治疗 

分 类 号：R735.1[医药卫生—肿瘤] R730.55[医药卫生—临床医学]